EZH2 couples pancreatic regeneration to neoplastic progression

被引:99
作者
Mallen-St Clair, Jon [1 ]
Soydaner-Azeloglu, Rengin [1 ]
Lee, Kyoung Eun [1 ]
Taylor, Laura [1 ]
Livanos, Alexandra
Pylayeva-Gupta, Yuliya [1 ]
Miller, George [2 ]
Margueron, Raphael [1 ]
Reinberg, Danny [1 ,3 ]
Bar-Sagi, Dafna [1 ]
机构
[1] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Surg, New York, NY 10016 USA
[3] Howard Hughes Med Inst, New York, NY 10016 USA
关键词
EZH2; pancreas; regeneration; cancer; TUMOR-CELL PROLIFERATION; ACINAR-CELL; BETA-CELL; EXPRESSION; CANCER; INFLAMMATION; METHYLATION; ENHANCER; HEDGEHOG; GENE;
D O I
10.1101/gad.181800.111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the polycomb group protein Enhancer of Zeste Homolog 2 (EZH2) is well recognized for its role as a key regulator of cell differentiation, its involvement in tissue regeneration is largely unknown. Here we show that EZH2 is up-regulated following cerulein-induced pancreatic injury and is required for tissue repair by promoting the regenerative proliferation of progenitor cells. Loss of EZH2 results in impaired pancreatic regeneration and accelerates KRas(G12D)-driven neoplasia. Our findings implicate EZH2 in constraining neoplastic progression through homeostatic mechanisms that control pancreatic regeneration and provide insights into the documented link between chronic pancreatic injury and an increased risk for pancreatic cancer.
引用
收藏
页码:439 / 444
页数:6
相关论文
共 50 条
  • [31] Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
    Zhang, Qi
    Han, Qi
    Zi, Jie
    Ma, Jinlong
    Song, Huihui
    Tian, Yulu
    McGrath, Mary
    Song, Chunhua
    Ge, Zheng
    [J]. GENES & DISEASES, 2019, 6 (03) : 276 - 281
  • [32] Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors
    Gibaja, V.
    Shen, F.
    Harari, J.
    Korn, J.
    Ruddy, D.
    Saenz-Vash, V.
    Zhai, H.
    Rejtar, T.
    Paris, C. G.
    Yu, Z.
    Lira, M.
    King, D.
    Qi, W.
    Keen, N.
    Hassan, A. Q.
    Chan, H. M.
    [J]. ONCOGENE, 2016, 35 (05) : 558 - 566
  • [33] Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
    Ernst, Thomas
    Chase, Andrew J.
    Score, Joannah
    Hidalgo-Curtis, Claire E.
    Bryant, Catherine
    Jones, Amy V.
    Waghorn, Katherine
    Zoi, Katerina
    Ross, Fiona M.
    Reiter, Andreas
    Hochhaus, Andreas
    Drexler, Hans G.
    Duncombe, Andrew
    Cervantes, Francisco
    Oscier, David
    Boultwood, Jacqueline
    Grand, Francis H.
    Cross, Nicholas C. P.
    [J]. NATURE GENETICS, 2010, 42 (08) : 722 - U109
  • [34] The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
    Wu, Shi-yi
    Xie, Zhao-yu
    Yan, Lu-yu
    Liu, Xiao-fang
    Zhang, Yue
    Wang, Da-an
    Dong, Jie
    Sun, Hong-tao
    [J]. BMC IMMUNOLOGY, 2022, 23 (01)
  • [35] Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
    Hong, Seong Hwi
    Hwang, Hyun Ji
    Son, Da Hyeon
    Kim, Eun Song
    Park, Sung Yul
    Yoon, Young Eun
    [J]. FEBS OPEN BIO, 2023, 13 (04): : 724 - 735
  • [36] EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression
    Drelon, Coralie
    Berthon, Annabel
    Mathieu, Mickael
    Ragazzon, Bruno
    Kuick, Rork
    Tabbal, Houda
    Septier, Amandine
    Rodriguez, Stephanie
    Batisse-Lignier, Marie
    Sahut-Barnola, Isabelle
    Dumontet, Typhanie
    Pointud, Jean-Christophe
    Lefrancois-Martinez, Anne-Marie
    Baron, Silvere
    Giordano, Thomas J.
    Bertherat, Jerome
    Martinez, Antoine
    Val, Pierre
    [J]. HUMAN MOLECULAR GENETICS, 2016, 25 (13) : 2789 - 2800
  • [37] Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification
    Xu, Cheng-Ran
    Li, Lin-Chen
    Donahue, Greg
    Ying, Lei
    Zhang, Yu-Wei
    Gadue, Paul
    Zaret, Kenneth S.
    [J]. EMBO JOURNAL, 2014, 33 (19) : 2157 - 2170
  • [38] EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
    Guo, Shuangping
    Li, Xia
    Rohr, Joseph
    Wang, Yingmei
    Ma, Shirong
    Chen, Peng
    Wang, Zhe
    [J]. DIAGNOSTIC PATHOLOGY, 2016, 11
  • [39] LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2
    Guo, Yongjian
    Bai, Mingjun
    Lin, Liteng
    Huang, Jingjun
    An, Yongcheng
    Liang, Licong
    Liu, Yaohong
    Huang, Wensou
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [40] Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia
    Zhu, Qiuhua
    Zhang, Lingxiu
    Li, Xiaodong
    Chen, Fang
    Jiang, Ling
    Yu, Guopan
    Wang, Zhixiang
    Yin, Changxin
    Jiang, Xuejie
    Zhong, Qingxiu
    Zhou, Hongsheng
    Ding, Bingjie
    Wang, Chunli
    Meng, Fanyi
    [J]. TUMOR BIOLOGY, 2016, 37 (08) : 11409 - 11420